Gilead Sciences
GILD
NASDAQ
IPO1992
about GILD
Gilead Sciences develops innovative pharmaceuticals to treat conditions such as HIV/AIDS, hepatitis C, and other serious diseases.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $140.41 | $140.78 | $138.87 | $174.9B | 1.84M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$2.46 | 23.23 | 22.61 | 42.82% | 39.28% | 2.26% |